Evaluation of spontaneous adverse event reports for osteonecrosis of the jaw (ONJ) attributed to denosumab and zoledronic acid within the fda adverse events reporting system (FAERS)

Conference proceeding

Peer reviewed

Mekkawy MA, El Fass K, Mohammad RN, Abou Ali A and Kareem El-Fass

Vol.26, pp.395-396

33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2017-08-26 to 2017-08-30

2017

Abstract

denosumab

1 Record Views

Title: Evaluation of spontaneous adverse event reports for osteonecrosis of the jaw (ONJ) attributed to denosumab and zoledronic acid within the fda adverse events reporting system (FAERS)
Creators - without role: Mekkawy MA
El Fass K
Mohammad RN
Abou Ali A
Kareem El-Fass - King Faisal University
Publication Details: Vol.26, pp.395-396
Conference: 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2017-08-26 to 2017-08-30
Publisher: John Wiley and Sons Ltd
Identifiers: 9919632708331
Academic Unit: King Faisal University
Language: English
Resource Type: Conference proceeding